Analyst Reco. Zimmer Biomet Holdings, Inc.

Equities

ZBH

US98956P1021

Market Closed - Nyse Other stock markets 04:03:22 2024-05-17 pm EDT			5-day change	1st Jan Change
120.2 ^USD	-0.87%		-0.93%	-1.25%

May. 13	Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024, Payable on or About July 31, 2024	CI
May. 03	Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142	May. 03	MT
UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating	May. 03	MT
Truist Adjusts Zimmer Biomet Holdings' PT to $130 From $137, Keeps Hold Rating	May. 03	MT
Bernstein Adjusts Price Target on Zimmer Biomet to $133 From $132	May. 03	MT
Jefferies Adjusts Price Target on Zimmer Biomet to $135 From $136	May. 03	MT
Citigroup Adjusts Price Target on Zimmer Biomet to $134 From $140	May. 03	MT
Morgan Stanley Adjusts Price Target on Zimmer Biomet to $130 From $135	May. 03	MT
Jefferies Adjusts Zimmer Biomet Price Target to $135 From $136	May. 03	MT
Citigroup Adjusts Zimmer Biomet Price Target to $134 From $140	May. 03	MT
Morgan Stanley Adjusts Zimmer Biomet Price Target to $130 From $135	May. 03	MT
Oppenheimer Adjusts Price Target on Zimmer Biomet Holdings to $155 From $150	May. 03	MT
BTIG Adjusts Price Target on Zimmer Biomet to $139 From $138, Keeps Buy Rating	May. 02	MT
Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept	Apr. 15	MT
Citigroup Raises Price Target on Zimmer Biomet to $140 From $134, Keeps Neutral Rating	Apr. 03	MT
UBS Adjusts Zimmer Biomet Price Target to $109 From $105, Maintains Sell Rating	Feb. 09	MT
Deutsche Bank Adjusts Zimmer Biomet Price Target to $140 From $147, Maintains Hold Rating	Feb. 09	MT
UBS Raises Zimmer Biomet Price Target to $105 From $99, Maintains Sell Rating	Jan. 22	MT
RBC Raises Price Target on Zimmer Biomet Holdings to $140 From $134, Keeps Outperform Rating	Jan. 12	MT
Evercore ISI Downgrades Zimmer Biomet to In Line From Outperform, Adjusts Price Target to $125 From $135	Jan. 04	MT
Raymond James Raises Zimmer Biomet's Price Target to $137 From $133, Maintains Outperform Rating	Jan. 03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Zimmer Biomet Holdings, Inc.

Equities

ZBH

US98956P1021

Analyst Reco.

Filters